Targeting Tumor Suppressor MicroRNAs in Pediatric Acute Lymphoblastic Leukemia |
The Johns Hopkins University School of Medicine / Linda Resar, M.D. |
Innovation Grants |
2014 |
Maryland |
Trib2 in the Pathogenesis of T-ALL |
University of Pennsylvania / Warren Pear, M.D., Ph.D., |
Innovation Grants |
2014 |
Pennsylvania |
Correction of Hematopoietic Defects in Down Syndrome by Chromosome 21 Silencing |
University of Massachusetts Medical School / Peter Newburger, M.D. |
Innovation Grants |
2014 |
Massachusetts |
Role of LMO1 in Neuroblastoma Initiation and Maintenance: Analysis in the Zebrafish model of Childhood Neuroblastoma |
Dana-Farber Cancer Institute / Thomas Look, M.D. |
Innovation Grants |
2014 |
Massachusetts |
Identifying Drug Resistant Mutations in Ph-like Acute Lymphoblastic Leukemia |
University of California San Francisco / Mignon Loh, M.D. |
Innovation Grants |
2014 |
California |
Mechanisms of LGR5 Regulation and Function in Ewing sarcoma Metastasis |
University of Michigan / Elizabeth Lawlor, M.D., Ph.D. |
Innovation Grants |
2014 |
Michigan |
Modeling the Multi-hit Pathogenesis of t(12;21) Associated Pediatric ALL by CRISPR/Cas-mediated Genome Engineering |
Massachusetts General Hospital / Hanno Hock, M.D., Ph.D. |
Innovation Grants |
2014 |
Massachusetts |
Developing Personalized (precision) Medicine Strategies to Optimize Pediatric Brain Tumor Management |
Washington University / David Gutmann, M.D., Ph.D. |
Innovation Grants |
2014 |
Missouri |
Two-pronged Cell Therapy: Engineering T Cells to Redirect Bystander T- and NK-Cells to Pediatric Cancer |
Baylor College of Medicine / Stephen Gottschalk, M.D. |
Innovation Grants |
2014 |
Texas |
Development of AAV Vectors for Efficient Targeting and Elimination of Osteosarcoma Tumor-Initiating Cells |
University of Florida / Steven Ghivizzani, Ph.D. |
Innovation Grants |
2014 |
Florida |